Company / CapEx per Share
Glaukos Corp. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.14
FY2025
5-year range
$0.13 / $1.06
FY2021-FY2025
Trend
+5.9%
vs FY2024
Sector context
#118 of 142
Health Care
What the data says
Glaukos Corp.'s capex per share of $0.14 is lower than 83% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 3 years of decline, reaching $0.14.
Based on SEC 10-K filings.
0.14 in FY2025 with a 5-year CAGR of -3.2%.
Declined from $0.42 to $0.14 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -40.5%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 142This company $0.14 Sector average $1.70
▼
-92.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 5.9% year-over-year.
- Ranks #118 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +5.9% |
| FY2024 | $0.13 | -69.8% |
| FY2023 | $0.42 | -34.2% |
| FY2022 | $0.64 | -39.0% |
| FY2021 | $1.06 | +562.5% |
| FY2020 | $0.16 | +21.8% |
| FY2019 | $0.13 | -56.1% |
| FY2018 | $0.30 | +60.3% |
| FY2017 | $0.19 | -4.7% |
| FY2016 | $0.20 | -45.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026